Evaluation of two automated systems for colistin susceptibility testing of carbapenem-resistant Acinetobacter baumannii clinical isolates

Journal of Antimicrobial Chemotherapy

Volumn 72, Issue 9, 2017, Pages 2528-2530

  Vourli, Sophia ^a   Dafopoulou, Konstantina ^b   Vrioni, Georgia ^b   Tsakris, Athanassios ^b   Pournaras, Spyros ^a,b  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; AGAR DILUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BROTH DILUTION; CARBAPENEM RESISTANT ACINETOBACTER BAUMANNII; CONTROLLED STUDY; GREECE; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; RANDOMIZED CONTROLLED TRIAL; TERTIARY CARE CENTER; AUTOMATION; DEVICES; DRUG EFFECTS; EVALUATION STUDY; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; PROCEDURES;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; AUTOMATION; CARBAPENEMS; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GREECE; HUMANS; MICROBIAL SENSITIVITY TESTS; TERTIARY CARE CENTERS;

EID: 85042181690     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkx186     Document Type: Article

References (17)

1. Karaiskos I, Giamarellou H. Multidrug-resistant and extensively drugresistant Gram-negative pathogens: current and emerging therapeutic approaches. Expert Opin Pharmacother 2014; 15: 1351-70
2. EUCAST. Recommendations for Colistin (Polymyxin E) MIC Testing-Joint EUCAST and CLSI Recommendation. 2016. http://www.eucast.org/fileadmin/ src/media/PDFs/EUCAST_files/General_documents/Recommendations_for_ MIC_determination_of_colistin_March_2016.pdf
3. Dafopoulou K, Zarkotou O, Dimitroulia E et al. Comparative evaluation of colistin susceptibility testing methods among carbapenem-non-susceptible Klebsiella pneumoniae and Acinetobacter baumannii clinical isolates. Antimicrob Agents Chemother 2015; 59: 4625-30
4. EUCAST. EUCAST Warnings Concerning Antimicrobial Susceptibility Testing Products or Procedures-Antimicrobial Susceptibility Testing of Colistin-Problems Detected with Several Commercially Available Products. 2016. http://www.eucast.org/ast_of_bacteria/warn ings/#c13111
5. Pournaras S, Dafopoulou K, Del Franco M et al. Predominance of international clone 2 OXA-23-producing-Acinetobacter baumannii clinical isolates in Greece, 2015: results of a nationwide study. Int J Antimicrob Agents 2017; 49: 749-53
6. Pournaras S, Gogou V, GiannouliMet al. Single-locus-sequence-based typing of blaOXA-51-like genes for rapid assignment of Acinetobacter baumannii clinical isolates to international clonal lineages. J Clin Microbiol 2014; 52: 1653-7
7. ECDC. Antimicrobial Resistance Surveillance in Europe 2015. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm, Sweden: ECDC, 2017
8. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically-Tenth Edition: Approved Standard M07-A10. CLSI,Wayne,PA, USA, 2015
9. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Seventh Informational Supplement M100-S27. CLSI, Wayne, PA, USA, 2017
10. Pournaras S, Poulou A, Dafopoulou K et al. Growth retardation, reduced invasiveness, and impaired colistin-mediated cell death associated with colistin resistance development in Acinetobacter baumannii. Antimicrob Agents Chemother 2014; 58: 828-32
11. EUCAST. Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 7.0. 2017. http://www.eucast.org/clinical_breakpoints/
12. International Organization for Standardization (ISO). Clinical Laboratory Testing and In Vitro Diagnostic Test Systems. Susceptibility Testing of Infectious Agents and Evaluation of Performance of Antimicrobial Susceptibility Test Devices. Part 2: Evaluation of Performance of Antimicrobial Susceptibility Test Devices. International Standard 20776-2. Geneva, Switzerland: ISO, 2007
13. Jerke KH, Lee MJ, Humphries RM. Polymyxin susceptibility testing: a cold case reopened. Clin Microbiol Newsl 2016; 38: 69-77
14. Lo-Ten-Foe JR, de Smet AM, Diederen BM et al. Comparative evaluation of the VITEK2, disk diffusion, Etest, brothmicrodilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains. Antimicrob Agents Chemother 2007; 51: 3726-30
15. Lee SY, Shin JH, Lee K et al. Comparison of the Vitek2, MicroScan, and Etestmethods with the agar dilution method in assessing colistin susceptibility of bloodstream isolates of Acinetobacter species froma Korean university hospital. J ClinMicrobiol 2013; 51: 1924-6
16. Tan TY, Ng SY. Comparison of Etest, Vitek and agar dilution for susceptibility testing of colistin. Clin Microbiol Infect 2007; 13: 541-4
17. Piewngam P, Kiratisin P. Comparative assessment of antimicrobial susceptibility testing for tigecycline and colistin against Acinetobacter baumannii clinical isolates, including multidrug-resistant isolates. Int J Antimicrob Agents 2014; 44: 396-401